Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Clarity Ad bevestigt: lecanemab vertraagt achteruitgang bij vroege Alzheimer
dec 2022 | Dementie